The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $35.75

Today's change+0.34 +0.96%
Updated February 27 4:01 PM EST. Delayed by at least 15 minutes.
 

Teva Pharmaceutical Industries Ltd

NYSE: TEVA
Last

(U.S.) $35.75

Today's change+0.34 +0.96%
Updated February 27 4:01 PM EST. Delayed by at least 15 minutes.

Teva Pharmaceutical Industries Ltd up (U.S.)$0.34

Teva Pharmaceutical Industries Ltd closed up Monday by (U.S.)$0.34 or 0.96% to (U.S.)$35.75. Over the last five days, shares have gained 1.56%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 58.91% during the last year.

Key company metrics

  • Open(U.S.) $35.40
  • Previous close(U.S.) $35.41
  • High(U.S.) $35.88
  • Low(U.S.) $35.22
  • Bid / Ask-- / --
  • YTD % change-1.38%
  • Volume5,735,104
  • Average volume (10-day)13,497,147
  • Average volume (1-month)13,314,958
  • Average volume (3-month)11,356,414
  • 52-week range(U.S.) $31.90 to (U.S.) $59.35
  • Beta0.62
  • Trailing P/E230.76×
  • P/E 1 year forward7.51×
  • Forward PEG3.05×
  • Indicated annual dividend(U.S.) $1.36
  • Dividend yield3.80%
  • Trailing EPS(U.S.) $0.15
Updated February 27 4:01 PM EST. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue6,4925,5635,0384,810
Total other revenue--------
Total revenue6,4925,5635,0384,810
Gross profit3,3902,8012,8772,791
Total cost of revenue3,1022,7622,1612,019
Total operating expense6,6294,7984,6773,645
Selling / general / administrative1,4401,2501,2631,143
Research & development684663375389
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,40372079231
Other operating expenses, total---5978663
Operating income-1377653611,165
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-914615256867
Income after tax-971408227639
Income tax, total5720729228
Net income-973412254636
Total adjustments to net income-65-64-66-66
Net income before extra. items-973412254636
Minority interest12123
Equity in affiliates-3215-6
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1,038348188570
Inc. avail. to common incl. extra. items-1,038348188570
Diluted net income-1,038348188570
Dilution adjustment0000
Diluted weighted average shares1,015984920920
Diluted EPS excluding extraordinary itemsvalue per share-1.020.350.200.62
Dividends per sharevalue per share0.340.340.340.34
Diluted normalized EPSvalue per share-0.120.840.970.64